1. Academic Validation
  2. Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia

Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-κB signaling pathways in LPS-activated BV-2 microglia

  • Pharmacol Res. 2018 Jul;133:218-235. doi: 10.1016/j.phrs.2018.01.014.
Sisi Qin 1 Canhong Yang 1 Weihua Huang 1 Shuhua Du 1 Hantao Mai 1 Jijie Xiao 2 Tianming Lü 3
Affiliations

Affiliations

  • 1 Department of Neurology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, PR China.
  • 2 Department of Medical Imaging, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, PR China.
  • 3 Department of Neurology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, PR China. Electronic address: [email protected].
Abstract

Sulforaphane (SFN), a natural dietary isothiocyanate in cruciferous vegetables such as broccoli and cabbage, has very strong anti-inflammatory activity. Activation of microglia leads to overexpression of a series of pro-inflammatory mediators, which play a vital role in neuronal damage. SFN may have neuroprotective effects in different neurodegenerative diseases related to inflammation. However, the mechanisms underlying SFN's protection of neurons against microglia-mediated neuronal damage are not fully understood. Here, we investigated how SFN attenuated microglia-mediated neuronal damage. Our results showed that SFN could not directly protect the viability of neurons following pro-inflammatory mediators, but increased the viability of BV-2 microglia and down-regulated the mRNA and protein levels of pro-inflammatory mediators including TNF-α, IL-1β, IL-6 and iNOS in a concentration-dependent manner in BV-2 cells. SFN also significantly blocked the phosphorylation of MAPKs (p38, JNK, and ERK1/2) and NF-κB p65, both by itself and with MAPK inhibitors (SB203580, SP 600125, and U0126) or an NF-κB Inhibitor (PDTC). The expression of pro-inflammatory proteins was also blocked by SFN with or without inhibitors. Further, SFN indirectly increased the viability and maintained the morphology of neurons, and the protein expression of RIPK3 and MLKL was significantly suppressed by SFN in neuronal Necroptosis through p38, JNK, and NF-κB p65 but not ERK1/2 signaling pathways. Together, our results demonstrate that SFN attenuates LPS-induced pro-inflammatory responses through down-regulation of MAPK/NF-κB signaling pathway in BV-2 microglia and thus indirectly suppresses microglia-mediated neuronal damage.

Keywords

Inflammation; Lipopolysaccharide (PubChem CID: 11970143); MAPK; Microglia; NF-κB; Necroptosis; SB203580 (PubChem CID: 176155); SP600125 (PubChem CID: 8515); Sulforaphane (PubChem CID: 5350); Sulforaphane (SFN); U0126 (PubChem CID: 3006531); glutamate (PubChem CID: 33032); l-glutamine (PubChem CID: 5961); penicillin (PubChem CID: 5904); pyrrolidine dithiocarbamate ammonium (PDTC) (PubChem CID: 65351); streptomycin (PubChem CID: 19649).

Figures
Products